This inventor holds 3 USPTO granted patents. Top assignees: Bio Science International, Inc., National Research Development Corporation. Active years: 1986-1994.
Company Filing History:
2 out of 4 
1 out of 1,200 
Years Active: 1986-1994
Title: **Innovations of Brian M Austen: Pioneering Diagnostic Methods for Pancreatic Disease**
Introduction
Brian M Austen is a distinguished inventor based in London, GB, known for his significant contributions to the field of medical diagnostics. With a portfolio of three patents, he has developed pioneering methods and tools that enhance the diagnosis and monitoring of pancreatic diseases. His innovative approaches leverage specific activation peptides derived from pancreatic zymogens, marking a notable advancement in clinical diagnostics.
Latest Patents
Austen's latest patents focus on the use of Zymogen Activation Peptides (ZAP) in the diagnosis of various pancreatic conditions. One of his notable innovations describes a method where pancreatic disease can be diagnosed by assaying a patient's body fluid, such as serum or urine, for pancreatic activation peptides (PAP) released from zymogens through proteolytic activation. His research emphasizes the utility of peptides featuring C-terminal D.sub.4 K sequences, allowing medical professionals to gain insights into the state of a patient’s pancreatic health.
His methods are particularly valuable, as they provide the ability to distinguish between necrotizing and oedematous acute pancreatitis, offer predictions of disease severity, and enable monitoring of chronic pancreatitis during exacerbations. Moreover, the diagnostic approaches outlined also exhibit efficacy in non-pancreatic diseases where similar zymogen activation occurs, showcasing the broader implications of his work in molecular pathology.
Career Highlights
Throughout his career, Brian M Austen has collaborated with reputable organizations, including Bio Science International, Inc. and the National Research Development Corporation. His work has significantly contributed to advancing diagnostic methodologies and improving patient outcomes in the medical field.
Collaborations
Austen has collaborated with leading professionals in his field, including John Hermon-Taylor and Steven Cliffe. These partnerships have fostered innovative approaches to research, contributing to the development of critical diagnostic tools and methods.
Conclusion
Brian M Austen stands out as a key inventor whose innovations in pancreatic disease diagnostics hold great promise for improving healthcare outcomes. His unique methodologies set a new standard for the detection and management of pancreatic conditions, reflecting his enduring commitment to scientific advancement and patient care.